Biopharma Insights
Leqembi, Donanemab and Tofersen: The End of the Journey or the First Step on the Road to Reversing Neurodegeneration?
Dr. Peter Hamley, Chief Scientific Officer at Samsara Therapeutics, explores whether developments in therapeutics for neurodegenerative diseases are truly disease modifying or addressing the symptoms of a deeper problem. Read more
16 Aug 2023
R&D revolution: A new paradigm of sourcing and landscaping for the pharma industry
Dr Robin Knight, Co-Founder & Co-CEO of IN-PART, discusses the emerging importance of outsourcing landscaping activities within the pharmaceuticals industry and the benefits of adopting an openly innovative approach that pools sources of innovation. Read more
12 Jul 2023
Enhancing Biotherapeutic Properties with Cell-Line Engineering
Neha Mishra, Ph.D, Senior Scientist Bioproduction at Revvity explores enhancing biotherapeutic properties with cell-line engineering. Read more
30 Jun 2023
Cell line development strategies fit for a new era of Bispecific Antibodies
Nicole Wakes, Senior Director Cell Line Development, and Simon Keen, Vice President Cell Line Development at Abzena, outline the strategies to overcome the challenges of developing BsAbs under increasing pressure for speed. Read more
26 Jun 2023
Science and tech combine to deliver cancer vaccine innovation
Scientific and technological innovation is accelerating the development of effective cancer vaccines, report Drs. Daina Vanags, Cori Gorman and Christian K. Schneider of Biopharma Excellence. Read more
12 Apr 2023
Leveraging RWE early is critical for emerging biopharma companies
Barbara Arone, vice president, real world solutions, IQVIA, examines the ways biotech and emerging biopharma companies can effectively apply real world evidence (RWE) early in the product lifecycle while staying within their resource limits. Read more
3 Mar 2023
Sage Therapeutics to Implement a 40% Workforce Reduction
Sage Therapeutics, Inc announced late last week plans to reorganise its business operations and pipeline priorities to support goals for long-term business growth. Read more
4 Sep 2023
IO Biotech Appoints Heidi Hunter to its Board of Directors
IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win technology platform, announced the appointment of Heidi Hunter to its board of directors. Read more
11 Aug 2023
Lytix Biopharma’s Licensing Partner Verrica Pharmaceuticals Reports Interim Phase 2 Data With LTX-315
Lytix Biopharma announces that its licensing partner Verrica Pharmaceuticals Inc has reported lesion clearance data from Part 1 of an ongoing Phase 2 study of VP-315 (formerly known as LTX 315) for the treatment of basal cell carcinoma (BCC). Read more
11 Aug 2023
Shutterstock
Safeguarding Brands and Patients: Layered Anti-Counterfeiting Measures in Packaging Design
David Gonzalez, Technical Account Manager, MM Packaging discusses ways of safeguarding brands and patients against counterfeit measures prominent in the world of pharma. Read more
27 Sep 2023
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Shutterstock
Scope 3 Emissions - More Than Suppliers
Dr Torill Bigg, Chief Carbon Reduction Scientist, Tunley Environmental explores scope 3 and how it can be the largest part by far of an organisation’s carbon footprint, and not all of them can justly be laid at the foot of the supply chain. Read more
27 Sep 2023
Shutterstock
Enhancing Speed and Accuracy in Drug Delivery and Packaging – The Importance of the Label
For our latest EPM Magazine issue, Laura Johnson, Loftware, Senior Director of Sales, Life Sciences, discusses the importance of the right label. Read more
27 Sep 2023
Shutterstock
In House, In Control, and In Demand
Kevin Queensen, mechanical engineer, Natoli, outlines the benefits of chrome coatings. Read more
26 Sep 2023
VIVEbiotech: A Lentiviral Vector Specialist Bridging the Gap Between R&D and Commercialisation
Natalia Elizalde PhD, Chief Business Development Officer, VIVEbiotech explores how the lentiviral vector specialists are bridging the gap between R&D and commercialisation. Read more
26 Sep 2023
Shutterstock
Beyond IDMP – Act Now to Reap the Benefits of eCTD 4.0 Compliance
Agnes Cwienczek, ALSS Head of Product Management and Consulting, ArisGlobal discusses the benefits of acting now to reap the benefits of eCTD 4.0 compliance. Read more
26 Sep 2023
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15
HERMES PHARMA GmbH
HERMES PHARMA is the leading expert in developing and manufacturing user-friendly oral dosage forms including effervescent and chewable tablets, instant drinks, lozenges, orally disintegrating granules and HERMES NutriCaps. Read more
